Consolidated Statements of Cash Flows - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2017	Jul. 31, 2017	Jul. 31, 2016
Cash flows provided by (used in) operating activities
Net loss	$ 1,379,379	$ 6,580,613	$ (7,814,256)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	2,142	5,140	2,389
Issuance of common stock for services		190,427	1,185,479
Stock based compensation from issuance of options	1,779,671	1,277,139	10,310,546
Loss on settlement of liability	13,917	0	0
Stock based compensation from issuance of warrants	0	229,360	0
Note payable issued for services	0	0	165,000
Changes in assets and liabilities:
Accounts receivable	(7,946,676)	(3,437,502)	(312,498)
Prepaid expenses and other current assets	(568,441)	(102,483)	(29,261)
Accounts payable and accrued expenses	1,145,021	2,071,387	(174,876)
Accrued salaries and wages	(987,870)	(1,218,065)	552,190
Royalty payable	1,408,012	0	0
Deferred revenue	(65,641)	(39,854)	(4,800,000)
Net cash used in operating activities	(3,840,486)	5,556,162	(915,287)
Cash flows used in investing activities
Purchase of property, plant and equipment	0	0	(7,537)
Net cash provided by financing activities	0	0	(7,537)
Cash flows provided by (used in) financing activities
Proceeds from warrant exercise	5,292,876	0	0
Deferred financing costs	(209,042)	0	0
Proceeds from related parties notes payable	0	0	151,191
Payments to related parties on notes payable	0	0	(281,191)
Repayment of note payable	0	(165,000)	0
Investment received in exchange for royalty agreement	0	0	2,100,000
Net cash provided by financing activities	5,083,834	(165,000)	1,970,000
Net increase in cash and cash equivalents	1,243,348	5,391,162	1,047,176
Cash and cash equivalents, beginning of period	6,872,555	1,481,393	434,217
Cash and cash equivalents, end of period	8,115,903	6,872,555	1,481,393
Supplemental disclosure
Interest paid during the period	0	4,828	78,865
Taxes paid during the period	619,225	0	0
Non-Cash Financing Transactions
Cashless exercise of options	146	0	15
Issuance of common stock as settlement of liability	200,000	0	0
Forgiveness of related party of debt	0	761,826	0
Reconciling adjustment to record shares issued in prior year for the conversion of debt into common stock and rounding in relation to 1-for-100 reverse stock split	$ 0	$ 6	$ 0